Express Pharma
Home  »  Archive  »  Adil Zainulbhai joins Cipla as Independent Director

Adil Zainulbhai joins Cipla as Independent Director

0 18
Read Article

Cipla has appointed Adil Zainulbhai as an independent director on the Board. Zainulbhai retired as Chairman of McKinsey India after a distinguished career consulting Indian corporations and their boards. He spent 24 years in the US where he led McKinsey’s Washington Office and founded the Minneapolis office before returning to India.

Dr YK Hamied, Chairman, Cipla said, “Adil’s 30+ years of experience across various industries in India and globally will add a valuable perspective to our Board of Directors.”

Zainulbhai said “Cipla has had a huge impact in providing affordable pharmaceuticals to the world while building a strong company. I look forward to helping Cipla become even more successful.”

Zainulbhai counsels the CEOs and promoters of large companies in a range of industries and has helped several such companies become global leaders. He works closely with Government leaders to drive growth, raise living standards, strengthen key sectors of the economy and improve healthcare, education, and welfare.

Recently, Zainulbhai co-edited the book, ‘Reimagining India: Unlocking the potential of Asia’s next superpower’ a seminal publication of 65 essays from leading thinkers around the world to explore the challenges and opportunities facing the country.

Zainulbhai grew up in Mumbai and graduated in Mechanical Engineering from the Indian Institute of Technology. He also has an MBA from Harvard Business School.

EP News BureauMumbai

Leave A Reply

Your email address will not be published.